Patents Assigned to American Cyanamid Comany
  • Reversal of multidrug resistance in human colon carcinoma cells
    Publication number: 20020169111
    Abstract: The present invention describes the use of fumitremorgin A, B and C and a series of diketopiperazines of Formula (I) to resensitize multidrug resistant (MDR) cancer cells to the cytotoxic effects of chemotherapeutic drugs.
    Type: Application
    Filed: February 28, 2002
    Publication date: November 14, 2002
    Applicant: American Cyanamid Comany
    Inventors: Haiyin He, Lee Martin Greenberger